OSA was reported to be a risk factor for increasing subjective pain intensity and lowering pain tolerance and thresholds [29], which may be attributed to potent pro-inflammatory mediators, such as C-reactive protein, TNF-α, IL-1β, IL-6, and CGRP which was also involving pain modulation, especially in migraine [30]. The gene discussed is IL1B; the disease is migraine disorder.